OV5-170710/CAPMC/ CIHR/Canada[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	2
2024	1
2025	0

Page 1

UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge.

Olukitibi TA, Ao Z, Azizi H, Ouyang MJ, Omole T, McKinnon L, Kobasa D, Coombs K, Kobinger G, Yao X. Olukitibi TA, et al. Front Biosci (Landmark Ed). 2024 May 20;29(5):195. doi: 10.31083/j.fbl2905195. Front Biosci (Landmark Ed). 2024. PMID: 38812326 Free article.

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection.

Olukitibi TA, Ao Z, Warner B, Unat R, Kobasa D, Yao X. Olukitibi TA, et al. Vaccines (Basel). 2023 Feb 24;11(3):545. doi: 10.3390/vaccines11030545. Vaccines (Basel). 2023. PMID: 36992129 Free PMC article. Review.

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses.

Ouyang MJ, Ao Z, Olukitibi TA, Lawrynuik P, Shieh C, Kung SKP, Fowke KR, Kobasa D, Yao X. Ouyang MJ, et al. Vaccines (Basel). 2023 Aug 23;11(9):1404. doi: 10.3390/vaccines11091404. Vaccines (Basel). 2023. PMID: 37766083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year